Mingfeng Zhang

ORCID: 0000-0001-7355-1880
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic function and diabetes
  • Glycosylation and Glycoproteins Research
  • FOXO transcription factor regulation
  • Ubiquitin and proteasome pathways
  • Endoplasmic Reticulum Stress and Disease
  • Peptidase Inhibition and Analysis

City of Hope
2021-2025

Beckman Research Institute
2021

The most prevalent types of lymphomas are B cell (BCL). Newer therapies for BCL have improved the prognosis many patients. However, approximately 30% with aggressive either remain refractory or ultimately relapse. These patients urgently need other options. This study shows how calcium/calmodulin-dependent protein kinase II delta (CAMKIIδ) is pivotal development. In cells, ablation CAMKIIδ inhibits both lipolysis from lipid droplets and oxidative phosphorylation (OXPHOS). With blocked,...

10.1002/advs.202409513 article EN cc-by Advanced Science 2025-01-22

Abstract B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with mixed-lineage gene rearrangement (MLL-r) is a poor-prognosis subtype for which additional therapeutic targets are urgently needed. Currently no multi omics data set primary MLL r patient cells exists that integrates transcriptomics, proteomics and glycomics to gain an inclusive picture of theranostic targets. Methods We have integrated i) obtain the first BCP-ALL identify molecular signatures distinguish leukemic from...

10.1101/2021.06.25.21259296 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2021-06-30
Coming Soon ...